TUESDAY, June 25, 2024 -- A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects...

Prolonged-release ketamine tablet has potential as affordable and convenient treatment for severe depression and with minimal side effects

A novel tablet formulation of ketamine has demonstrated potential in the treatment of severe depression, providing a possible substitute for the...

A new pill that releases ketamine slowly over time could treat severe depression without causing the psychedelic side effects often associated with...

AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from...

More than 85% of women – and more than 300 million people worldwide at any given time – use hormonal contraceptives for at least five years of...

An analysis of data from a randomised clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib,...

Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had...

A new study from University College London (UCL) finds that people with anxiety are twice as likely to develop Parkinson’s disease compared to...